Bioventus (BVS) Net Margin (2020 - 2026)

Bioventus (BVS) has 6 years of Net Margin data on file, last reported at 2.99% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin rose 567.0% year-over-year to 2.99%; the trailing twelve-month figure through Mar 2026 stood at 5.99% (up 658.0% YoY), and the FY2023 full-year result was 14.53%, down 110.0% from the prior year.
• Net Margin for Q1 2026 stood at 2.99%, down from 10.97% in the prior quarter.
• Across five years, Net Margin topped out at 10.97% in Q4 2025 and bottomed at 62.51% in Q2 2023.
• The 4-year median for Net Margin is 0.27% (2022), against an average of 9.59%.
• The widest annual swing landed in 2022, when Net Margin jumped 962 bps; it then sank 6217 bps in 2023.
• A 4-year view of Net Margin shows it stood at 18.59% in 2022, then slumped by 236 bps to 62.51% in 2023, then surged by 118 bps to 10.97% in 2025, then tumbled by 73 bps to 2.99% in 2026.
• The last three Net Margin figures came in at 2.99% (Q1 2026), 10.97% (Q4 2025), and 2.89% (Q3 2025), per Business Quant data.

Peer Comparison